Clinical trials

  • SKB410 for High-risk non-muscle invasive bladder cancer (NMIBC) | Carcinoma in situ (CIS)
  • TRAMETINIB for Papillary craniopharyngioma
  • dinoprostone for Premature rupture of membranes (PROM)
  • Autologous T-cells transduced with lentiviral vector expressing a chimeric antigen receptor directed against CD19 for Systemic sclerosis (scleroderma)
  • SODIUM TRANS-[TETRACHLOROBIS(1H-INDAZOLE)RUTHENATE(III) DIHYDRATE for Colorectal cancer|Gastric cancer|Cholangiocarcinoma|Advanced solid gastrointestinal tumours|Pancreatic cancer
  • Canis familiaris (553) for Allergic rhinitis due to dog allergy
  • ENTR-601-45 for Duchenne muscular dystrophy
  • SIROLIMUS for End-stage kidney disease | Type 1 diabetes
  • siRNA (nucleic acid) — complex RNA oligonucleotide (as listed in product details) for Antibody-mediated rejection after kidney transplantation|Antibody-mediated rejection
  • dextromethorphan; deramciclane fumarate for Agitation in Alzheimer's disease dementia
  • DRY EXTRACT FROM PSILOCYBE CUBENSIS (15-25:1), EXTRACTION SOLVENT: METHANOL for Alcohol use disorder
  • AUTOLOGOUS ADIPOSE TISSUE-DERIVED STROMAL VASCULAR FRACTION CELLS for Scarred vocal folds